Literature DB >> 11544564

B lymphopoiesis is upregulated after orchiectomy and is correlated with estradiol but not testosterone serum levels in aged male rats.

R G Erben1, J Eberle, M Stangassinger.   

Abstract

Previous studies have shown that B lymphopoiesis is augmented after androgen withdrawal in male mice. As an analogy to the skeletal system, some effects of androgens on the proliferation of B cells may be mediated via aromatization into estrogens in vivo. The aim of the present study was to assess the effects of androgen withdrawal on B lymphopoiesis in bone marrow of aged male rats sequentially over a period of 9 months, and to correlate the flow-cytometric findings with changes in systemic levels of sex steroids. We first showed that androgen withdrawal is associated with enhanced B lymphopoiesis in bone marrow of 4-month-old male orchiectomized (ORX) rats, and that the changes in the bone marrow B cell compartment in ORX animals can be reversed by testosterone supplementation. In a subsequent, sequential experiment, we found that orchiectomy induced a sustained rise in Thy 1.1+/CD45R+ bone marrow cells committed for the B cell lineage that lasted for several months in 13-month-old aged rats. In a stepwise model of multiple regression analysis using estradiol, free and total testosterone as independent variables, estradiol was the strongest predictor of the percentage of B precursor cells in bone marrow in aged SHAM and ORX rats. Free and total testosterone did not correlate with B lymphopoiesis in aged SHAM rats. The current experiment has clearly shown that androgen withdrawal upregulates the number of B lineage cells over several months in rat bone marrow. Furthermore, our results provide evidence that estradiol may play an important role as a physiological suppressor of B lymphopoiesis in aged male rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544564     DOI: 10.1055/s-2001-16943

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  8 in total

Review 1.  Clinical strategies to enhance T cell reconstitution.

Authors:  Gabrielle L Goldberg; Johannes L Zakrzewski; Miguel A Perales; Marcel R M van den Brink
Journal:  Semin Immunol       Date:  2007-10-26       Impact factor: 11.130

Review 2.  Greater than the sum of their parts: combination strategies for immune regeneration following allogeneic hematopoietic stem cell transplantation.

Authors:  Jarrod A Dudakov; Marcel R M van den Brink
Journal:  Best Pract Res Clin Haematol       Date:  2011-06-29       Impact factor: 3.020

Review 3.  Hematological changes during androgen deprivation therapy.

Authors:  Mathis Grossmann; Jeffrey D Zajac
Journal:  Asian J Androl       Date:  2012-01-09       Impact factor: 3.285

4.  Oestrogen receptor specificity in oestradiol-mediated effects on B lymphopoiesis and immunoglobulin production in male mice.

Authors:  M C Erlandsson; C A Jonsson; U Islander; C Ohlsson; H Carlsten
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

5.  Reassessment of the role of Mut S homolog 5 in Ig class switch recombination shows lack of involvement in cis- and trans-switching.

Authors:  Jeroen E J Guikema; Carol E Schrader; Niek G J Leus; Anna Ucher; Erin K Linehan; Uwe Werling; Winfried Edelmann; Janet Stavnezer
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

6.  Androgen receptor increases CD133 expression and progenitor-like population that associate with cisplatin resistance in endometrial cancer cell line.

Authors:  Lumin Chen; Wei-Chun Chang; Yao-Ching Hung; Ying-Yi Chang; Bo-Yin Bao; Hsin-Ching Huang; Wei-Min Chung; Chih-Rong Shyr; Wen-Lung Ma
Journal:  Reprod Sci       Date:  2013-08-20       Impact factor: 3.060

7.  Zfp318 regulates IgD expression by abrogating transcription termination within the Ighm/Ighd locus.

Authors:  Peter D Pioli; Irina Debnath; Janis J Weis; John H Weis
Journal:  J Immunol       Date:  2014-07-23       Impact factor: 5.422

Review 8.  Sex steroids and stem cell function.

Authors:  Rinki Ray; Nathan M Novotny; Paul R Crisostomo; Tim Lahm; Aaron Abarbanell; Daniel R Meldrum
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.